103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024
HB3926

 

Introduced 2/17/2023, by Rep. Janet Yang Rohr

 

SYNOPSIS AS INTRODUCED:
 
105 ILCS 5/22-30

    Amends the General Provisions Article of the School Code. In provisions concerning administration of an opioid antagonist, provides that a school district, public school, charter school, or nonpublic school shall maintain a supply of an opioid antagonist in any secure location where an individual may have an opioid overdose (instead of may maintain a supply of an opioid antagonist in any secure location where an individual may have an opioid overdose). Makes a conforming change.


LRB103 27612 RJT 53988 b

 

 

A BILL FOR

 

HB3926LRB103 27612 RJT 53988 b

1    AN ACT concerning education.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The School Code is amended by changing Section
522-30 as follows:
 
6    (105 ILCS 5/22-30)
7    Sec. 22-30. Self-administration and self-carry of asthma
8medication and epinephrine injectors; administration of
9undesignated epinephrine injectors; administration of an
10opioid antagonist; administration of undesignated asthma
11medication; asthma episode emergency response protocol.
12    (a) For the purpose of this Section only, the following
13terms shall have the meanings set forth below:
14    "Asthma action plan" means a written plan developed with a
15pupil's medical provider to help control the pupil's asthma.
16The goal of an asthma action plan is to reduce or prevent
17flare-ups and emergency department visits through day-to-day
18management and to serve as a student-specific document to be
19referenced in the event of an asthma episode.
20    "Asthma episode emergency response protocol" means a
21procedure to provide assistance to a pupil experiencing
22symptoms of wheezing, coughing, shortness of breath, chest
23tightness, or breathing difficulty.

 

 

HB3926- 2 -LRB103 27612 RJT 53988 b

1    "Epinephrine injector" includes an auto-injector approved
2by the United States Food and Drug Administration for the
3administration of epinephrine and a pre-filled syringe
4approved by the United States Food and Drug Administration and
5used for the administration of epinephrine that contains a
6pre-measured dose of epinephrine that is equivalent to the
7dosages used in an auto-injector.
8    "Asthma medication" means quick-relief asthma medication,
9including albuterol or other short-acting bronchodilators,
10that is approved by the United States Food and Drug
11Administration for the treatment of respiratory distress.
12"Asthma medication" includes medication delivered through a
13device, including a metered dose inhaler with a reusable or
14disposable spacer or a nebulizer with a mouthpiece or mask.
15    "Opioid antagonist" means a drug that binds to opioid
16receptors and blocks or inhibits the effect of opioids acting
17on those receptors, including, but not limited to, naloxone
18hydrochloride or any other similarly acting drug approved by
19the U.S. Food and Drug Administration.
20    "Respiratory distress" means the perceived or actual
21presence of wheezing, coughing, shortness of breath, chest
22tightness, breathing difficulty, or any other symptoms
23consistent with asthma. Respiratory distress may be
24categorized as "mild-to-moderate" or "severe".
25    "School nurse" means a registered nurse working in a
26school with or without licensure endorsed in school nursing.

 

 

HB3926- 3 -LRB103 27612 RJT 53988 b

1    "Self-administration" means a pupil's discretionary use of
2his or her prescribed asthma medication or epinephrine
3injector.
4    "Self-carry" means a pupil's ability to carry his or her
5prescribed asthma medication or epinephrine injector.
6    "Standing protocol" may be issued by (i) a physician
7licensed to practice medicine in all its branches, (ii) a
8licensed physician assistant with prescriptive authority, or
9(iii) a licensed advanced practice registered nurse with
10prescriptive authority.
11    "Trained personnel" means any school employee or volunteer
12personnel authorized in Sections 10-22.34, 10-22.34a, and
1310-22.34b of this Code who has completed training under
14subsection (g) of this Section to recognize and respond to
15anaphylaxis, an opioid overdose, or respiratory distress.
16    "Undesignated asthma medication" means asthma medication
17prescribed in the name of a school district, public school,
18charter school, or nonpublic school.
19    "Undesignated epinephrine injector" means an epinephrine
20injector prescribed in the name of a school district, public
21school, charter school, or nonpublic school.
22    (b) A school, whether public, charter, or nonpublic, must
23permit the self-administration and self-carry of asthma
24medication by a pupil with asthma or the self-administration
25and self-carry of an epinephrine injector by a pupil, provided
26that:

 

 

HB3926- 4 -LRB103 27612 RJT 53988 b

1        (1) the parents or guardians of the pupil provide to
2    the school (i) written authorization from the parents or
3    guardians for (A) the self-administration and self-carry
4    of asthma medication or (B) the self-carry of asthma
5    medication or (ii) for (A) the self-administration and
6    self-carry of an epinephrine injector or (B) the
7    self-carry of an epinephrine injector, written
8    authorization from the pupil's physician, physician
9    assistant, or advanced practice registered nurse; and
10        (2) the parents or guardians of the pupil provide to
11    the school (i) the prescription label, which must contain
12    the name of the asthma medication, the prescribed dosage,
13    and the time at which or circumstances under which the
14    asthma medication is to be administered, or (ii) for the
15    self-administration or self-carry of an epinephrine
16    injector, a written statement from the pupil's physician,
17    physician assistant, or advanced practice registered nurse
18    containing the following information:
19            (A) the name and purpose of the epinephrine
20        injector;
21            (B) the prescribed dosage; and
22            (C) the time or times at which or the special
23        circumstances under which the epinephrine injector is
24        to be administered.
25The information provided shall be kept on file in the office of
26the school nurse or, in the absence of a school nurse, the

 

 

HB3926- 5 -LRB103 27612 RJT 53988 b

1school's administrator.
2    (b-5) A school district, public school, charter school, or
3nonpublic school may authorize the provision of a
4student-specific or undesignated epinephrine injector to a
5student or any personnel authorized under a student's
6Individual Health Care Action Plan, Illinois Food Allergy
7Emergency Action Plan and Treatment Authorization Form, or
8plan pursuant to Section 504 of the federal Rehabilitation Act
9of 1973 to administer an epinephrine injector to the student,
10that meets the student's prescription on file.
11    (b-10) The school district, public school, charter school,
12or nonpublic school may authorize a school nurse or trained
13personnel to do the following: (i) provide an undesignated
14epinephrine injector to a student for self-administration only
15or any personnel authorized under a student's Individual
16Health Care Action Plan, Illinois Food Allergy Emergency
17Action Plan and Treatment Authorization Form, plan pursuant to
18Section 504 of the federal Rehabilitation Act of 1973, or
19individualized education program plan to administer to the
20student that meets the student's prescription on file; (ii)
21administer an undesignated epinephrine injector that meets the
22prescription on file to any student who has an Individual
23Health Care Action Plan, Illinois Food Allergy Emergency
24Action Plan and Treatment Authorization Form, plan pursuant to
25Section 504 of the federal Rehabilitation Act of 1973, or
26individualized education program plan that authorizes the use

 

 

HB3926- 6 -LRB103 27612 RJT 53988 b

1of an epinephrine injector; (iii) administer an undesignated
2epinephrine injector to any person that the school nurse or
3trained personnel in good faith believes is having an
4anaphylactic reaction; (iv) administer an opioid antagonist to
5any person that the school nurse or trained personnel in good
6faith believes is having an opioid overdose; (v) provide
7undesignated asthma medication to a student for
8self-administration only or to any personnel authorized under
9a student's Individual Health Care Action Plan or asthma
10action plan, plan pursuant to Section 504 of the federal
11Rehabilitation Act of 1973, or individualized education
12program plan to administer to the student that meets the
13student's prescription on file; (vi) administer undesignated
14asthma medication that meets the prescription on file to any
15student who has an Individual Health Care Action Plan or
16asthma action plan, plan pursuant to Section 504 of the
17federal Rehabilitation Act of 1973, or individualized
18education program plan that authorizes the use of asthma
19medication; and (vii) administer undesignated asthma
20medication to any person that the school nurse or trained
21personnel believes in good faith is having respiratory
22distress.
23    (c) The school district, public school, charter school, or
24nonpublic school must inform the parents or guardians of the
25pupil, in writing, that the school district, public school,
26charter school, or nonpublic school and its employees and

 

 

HB3926- 7 -LRB103 27612 RJT 53988 b

1agents, including a physician, physician assistant, or
2advanced practice registered nurse providing standing protocol
3and a prescription for school epinephrine injectors, an opioid
4antagonist, or undesignated asthma medication, are to incur no
5liability or professional discipline, except for willful and
6wanton conduct, as a result of any injury arising from the
7administration of asthma medication, an epinephrine injector,
8or an opioid antagonist regardless of whether authorization
9was given by the pupil's parents or guardians or by the pupil's
10physician, physician assistant, or advanced practice
11registered nurse. The parents or guardians of the pupil must
12sign a statement acknowledging that the school district,
13public school, charter school, or nonpublic school and its
14employees and agents are to incur no liability, except for
15willful and wanton conduct, as a result of any injury arising
16from the administration of asthma medication, an epinephrine
17injector, or an opioid antagonist regardless of whether
18authorization was given by the pupil's parents or guardians or
19by the pupil's physician, physician assistant, or advanced
20practice registered nurse and that the parents or guardians
21must indemnify and hold harmless the school district, public
22school, charter school, or nonpublic school and its employees
23and agents against any claims, except a claim based on willful
24and wanton conduct, arising out of the administration of
25asthma medication, an epinephrine injector, or an opioid
26antagonist regardless of whether authorization was given by

 

 

HB3926- 8 -LRB103 27612 RJT 53988 b

1the pupil's parents or guardians or by the pupil's physician,
2physician assistant, or advanced practice registered nurse.
3    (c-5) When a school nurse or trained personnel administers
4an undesignated epinephrine injector to a person whom the
5school nurse or trained personnel in good faith believes is
6having an anaphylactic reaction, administers an opioid
7antagonist to a person whom the school nurse or trained
8personnel in good faith believes is having an opioid overdose,
9or administers undesignated asthma medication to a person whom
10the school nurse or trained personnel in good faith believes
11is having respiratory distress, notwithstanding the lack of
12notice to the parents or guardians of the pupil or the absence
13of the parents or guardians signed statement acknowledging no
14liability, except for willful and wanton conduct, the school
15district, public school, charter school, or nonpublic school
16and its employees and agents, and a physician, a physician
17assistant, or an advanced practice registered nurse providing
18standing protocol and a prescription for undesignated
19epinephrine injectors, an opioid antagonist, or undesignated
20asthma medication, are to incur no liability or professional
21discipline, except for willful and wanton conduct, as a result
22of any injury arising from the use of an undesignated
23epinephrine injector, the use of an opioid antagonist, or the
24use of undesignated asthma medication, regardless of whether
25authorization was given by the pupil's parents or guardians or
26by the pupil's physician, physician assistant, or advanced

 

 

HB3926- 9 -LRB103 27612 RJT 53988 b

1practice registered nurse.
2    (d) The permission for self-administration and self-carry
3of asthma medication or the self-administration and self-carry
4of an epinephrine injector is effective for the school year
5for which it is granted and shall be renewed each subsequent
6school year upon fulfillment of the requirements of this
7Section.
8    (e) Provided that the requirements of this Section are
9fulfilled, a pupil with asthma may self-administer and
10self-carry his or her asthma medication or a pupil may
11self-administer and self-carry an epinephrine injector (i)
12while in school, (ii) while at a school-sponsored activity,
13(iii) while under the supervision of school personnel, or (iv)
14before or after normal school activities, such as while in
15before-school or after-school care on school-operated property
16or while being transported on a school bus.
17    (e-5) Provided that the requirements of this Section are
18fulfilled, a school nurse or trained personnel may administer
19an undesignated epinephrine injector to any person whom the
20school nurse or trained personnel in good faith believes to be
21having an anaphylactic reaction (i) while in school, (ii)
22while at a school-sponsored activity, (iii) while under the
23supervision of school personnel, or (iv) before or after
24normal school activities, such as while in before-school or
25after-school care on school-operated property or while being
26transported on a school bus. A school nurse or trained

 

 

HB3926- 10 -LRB103 27612 RJT 53988 b

1personnel may carry undesignated epinephrine injectors on his
2or her person while in school or at a school-sponsored
3activity.
4    (e-10) Provided that the requirements of this Section are
5fulfilled, a school nurse or trained personnel may administer
6an opioid antagonist to any person whom the school nurse or
7trained personnel in good faith believes to be having an
8opioid overdose (i) while in school, (ii) while at a
9school-sponsored activity, (iii) while under the supervision
10of school personnel, or (iv) before or after normal school
11activities, such as while in before-school or after-school
12care on school-operated property. A school nurse or trained
13personnel may carry an opioid antagonist on his or her person
14while in school or at a school-sponsored activity.
15    (e-15) If the requirements of this Section are met, a
16school nurse or trained personnel may administer undesignated
17asthma medication to any person whom the school nurse or
18trained personnel in good faith believes to be experiencing
19respiratory distress (i) while in school, (ii) while at a
20school-sponsored activity, (iii) while under the supervision
21of school personnel, or (iv) before or after normal school
22activities, including before-school or after-school care on
23school-operated property. A school nurse or trained personnel
24may carry undesignated asthma medication on his or her person
25while in school or at a school-sponsored activity.
26    (f) The school district, public school, charter school, or

 

 

HB3926- 11 -LRB103 27612 RJT 53988 b

1nonpublic school may maintain a supply of undesignated
2epinephrine injectors in any secure location that is
3accessible before, during, and after school where an allergic
4person is most at risk, including, but not limited to,
5classrooms and lunchrooms. A physician, a physician assistant
6who has prescriptive authority in accordance with Section 7.5
7of the Physician Assistant Practice Act of 1987, or an
8advanced practice registered nurse who has prescriptive
9authority in accordance with Section 65-40 of the Nurse
10Practice Act may prescribe undesignated epinephrine injectors
11in the name of the school district, public school, charter
12school, or nonpublic school to be maintained for use when
13necessary. Any supply of epinephrine injectors shall be
14maintained in accordance with the manufacturer's instructions.
15    The school district, public school, charter school, or
16nonpublic school shall may maintain a supply of an opioid
17antagonist in any secure location where an individual may have
18an opioid overdose. A health care professional who has been
19delegated prescriptive authority for opioid antagonists in
20accordance with Section 5-23 of the Substance Use Disorder Act
21shall may prescribe opioid antagonists in the name of the
22school district, public school, charter school, or nonpublic
23school, to be maintained for use when necessary. Any supply of
24opioid antagonists shall be maintained in accordance with the
25manufacturer's instructions.
26    The school district, public school, charter school, or

 

 

HB3926- 12 -LRB103 27612 RJT 53988 b

1nonpublic school may maintain a supply of asthma medication in
2any secure location that is accessible before, during, or
3after school where a person is most at risk, including, but not
4limited to, a classroom or the nurse's office. A physician, a
5physician assistant who has prescriptive authority under
6Section 7.5 of the Physician Assistant Practice Act of 1987,
7or an advanced practice registered nurse who has prescriptive
8authority under Section 65-40 of the Nurse Practice Act may
9prescribe undesignated asthma medication in the name of the
10school district, public school, charter school, or nonpublic
11school to be maintained for use when necessary. Any supply of
12undesignated asthma medication must be maintained in
13accordance with the manufacturer's instructions.
14    (f-3) Whichever entity initiates the process of obtaining
15undesignated epinephrine injectors and providing training to
16personnel for carrying and administering undesignated
17epinephrine injectors shall pay for the costs of the
18undesignated epinephrine injectors.
19    (f-5) Upon any administration of an epinephrine injector,
20a school district, public school, charter school, or nonpublic
21school must immediately activate the EMS system and notify the
22student's parent, guardian, or emergency contact, if known.
23    Upon any administration of an opioid antagonist, a school
24district, public school, charter school, or nonpublic school
25must immediately activate the EMS system and notify the
26student's parent, guardian, or emergency contact, if known.

 

 

HB3926- 13 -LRB103 27612 RJT 53988 b

1    (f-10) Within 24 hours of the administration of an
2undesignated epinephrine injector, a school district, public
3school, charter school, or nonpublic school must notify the
4physician, physician assistant, or advanced practice
5registered nurse who provided the standing protocol and a
6prescription for the undesignated epinephrine injector of its
7use.
8    Within 24 hours after the administration of an opioid
9antagonist, a school district, public school, charter school,
10or nonpublic school must notify the health care professional
11who provided the prescription for the opioid antagonist of its
12use.
13    Within 24 hours after the administration of undesignated
14asthma medication, a school district, public school, charter
15school, or nonpublic school must notify the student's parent
16or guardian or emergency contact, if known, and the physician,
17physician assistant, or advanced practice registered nurse who
18provided the standing protocol and a prescription for the
19undesignated asthma medication of its use. The district or
20school must follow up with the school nurse, if available, and
21may, with the consent of the child's parent or guardian,
22notify the child's health care provider of record, as
23determined under this Section, of its use.
24    (g) Prior to the administration of an undesignated
25epinephrine injector, trained personnel must submit to the
26school's administration proof of completion of a training

 

 

HB3926- 14 -LRB103 27612 RJT 53988 b

1curriculum to recognize and respond to anaphylaxis that meets
2the requirements of subsection (h) of this Section. Training
3must be completed annually. The school district, public
4school, charter school, or nonpublic school must maintain
5records related to the training curriculum and trained
6personnel.
7    Prior to the administration of an opioid antagonist,
8trained personnel must submit to the school's administration
9proof of completion of a training curriculum to recognize and
10respond to an opioid overdose, which curriculum must meet the
11requirements of subsection (h-5) of this Section. Training
12must be completed annually. Trained personnel must also submit
13to the school's administration proof of cardiopulmonary
14resuscitation and automated external defibrillator
15certification. The school district, public school, charter
16school, or nonpublic school must maintain records relating to
17the training curriculum and the trained personnel.
18    Prior to the administration of undesignated asthma
19medication, trained personnel must submit to the school's
20administration proof of completion of a training curriculum to
21recognize and respond to respiratory distress, which must meet
22the requirements of subsection (h-10) of this Section.
23Training must be completed annually, and the school district,
24public school, charter school, or nonpublic school must
25maintain records relating to the training curriculum and the
26trained personnel.

 

 

HB3926- 15 -LRB103 27612 RJT 53988 b

1    (h) A training curriculum to recognize and respond to
2anaphylaxis, including the administration of an undesignated
3epinephrine injector, may be conducted online or in person.
4    Training shall include, but is not limited to:
5        (1) how to recognize signs and symptoms of an allergic
6    reaction, including anaphylaxis;
7        (2) how to administer an epinephrine injector; and
8        (3) a test demonstrating competency of the knowledge
9    required to recognize anaphylaxis and administer an
10    epinephrine injector.
11    Training may also include, but is not limited to:
12        (A) a review of high-risk areas within a school and
13    its related facilities;
14        (B) steps to take to prevent exposure to allergens;
15        (C) emergency follow-up procedures, including the
16    importance of calling 9-1-1 or, if 9-1-1 is not available,
17    other local emergency medical services;
18        (D) how to respond to a student with a known allergy,
19    as well as a student with a previously unknown allergy;
20        (E) other criteria as determined in rules adopted
21    pursuant to this Section; and
22        (F) any policy developed by the State Board of
23    Education under Section 2-3.190.
24    In consultation with statewide professional organizations
25representing physicians licensed to practice medicine in all
26of its branches, registered nurses, and school nurses, the

 

 

HB3926- 16 -LRB103 27612 RJT 53988 b

1State Board of Education shall make available resource
2materials consistent with criteria in this subsection (h) for
3educating trained personnel to recognize and respond to
4anaphylaxis. The State Board may take into consideration the
5curriculum on this subject developed by other states, as well
6as any other curricular materials suggested by medical experts
7and other groups that work on life-threatening allergy issues.
8The State Board is not required to create new resource
9materials. The State Board shall make these resource materials
10available on its Internet website.
11    (h-5) A training curriculum to recognize and respond to an
12opioid overdose, including the administration of an opioid
13antagonist, may be conducted online or in person. The training
14must comply with any training requirements under Section 5-23
15of the Substance Use Disorder Act and the corresponding rules.
16It must include, but is not limited to:
17        (1) how to recognize symptoms of an opioid overdose;
18        (2) information on drug overdose prevention and
19    recognition;
20        (3) how to perform rescue breathing and resuscitation;
21        (4) how to respond to an emergency involving an opioid
22    overdose;
23        (5) opioid antagonist dosage and administration;
24        (6) the importance of calling 9-1-1 or, if 9-1-1 is
25    not available, other local emergency medical services;
26        (7) care for the overdose victim after administration

 

 

HB3926- 17 -LRB103 27612 RJT 53988 b

1    of the overdose antagonist;
2        (8) a test demonstrating competency of the knowledge
3    required to recognize an opioid overdose and administer a
4    dose of an opioid antagonist; and
5        (9) other criteria as determined in rules adopted
6    pursuant to this Section.
7    (h-10) A training curriculum to recognize and respond to
8respiratory distress, including the administration of
9undesignated asthma medication, may be conducted online or in
10person. The training must include, but is not limited to:
11        (1) how to recognize symptoms of respiratory distress
12    and how to distinguish respiratory distress from
13    anaphylaxis;
14        (2) how to respond to an emergency involving
15    respiratory distress;
16        (3) asthma medication dosage and administration;
17        (4) the importance of calling 9-1-1 or, if 9-1-1 is
18    not available, other local emergency medical services;
19        (5) a test demonstrating competency of the knowledge
20    required to recognize respiratory distress and administer
21    asthma medication; and
22        (6) other criteria as determined in rules adopted
23    under this Section.
24    (i) Within 3 days after the administration of an
25undesignated epinephrine injector by a school nurse, trained
26personnel, or a student at a school or school-sponsored

 

 

HB3926- 18 -LRB103 27612 RJT 53988 b

1activity, the school must report to the State Board of
2Education in a form and manner prescribed by the State Board
3the following information:
4        (1) age and type of person receiving epinephrine
5    (student, staff, visitor);
6        (2) any previously known diagnosis of a severe
7    allergy;
8        (3) trigger that precipitated allergic episode;
9        (4) location where symptoms developed;
10        (5) number of doses administered;
11        (6) type of person administering epinephrine (school
12    nurse, trained personnel, student); and
13        (7) any other information required by the State Board.
14    If a school district, public school, charter school, or
15nonpublic school maintains or has an independent contractor
16providing transportation to students who maintains a supply of
17undesignated epinephrine injectors, then the school district,
18public school, charter school, or nonpublic school must report
19that information to the State Board of Education upon adoption
20or change of the policy of the school district, public school,
21charter school, nonpublic school, or independent contractor,
22in a manner as prescribed by the State Board. The report must
23include the number of undesignated epinephrine injectors in
24supply.
25    (i-5) Within 3 days after the administration of an opioid
26antagonist by a school nurse or trained personnel, the school

 

 

HB3926- 19 -LRB103 27612 RJT 53988 b

1must report to the State Board of Education, in a form and
2manner prescribed by the State Board, the following
3information:
4        (1) the age and type of person receiving the opioid
5    antagonist (student, staff, or visitor);
6        (2) the location where symptoms developed;
7        (3) the type of person administering the opioid
8    antagonist (school nurse or trained personnel); and
9        (4) any other information required by the State Board.
10    (i-10) Within 3 days after the administration of
11undesignated asthma medication by a school nurse, trained
12personnel, or a student at a school or school-sponsored
13activity, the school must report to the State Board of
14Education, on a form and in a manner prescribed by the State
15Board of Education, the following information:
16        (1) the age and type of person receiving the asthma
17    medication (student, staff, or visitor);
18        (2) any previously known diagnosis of asthma for the
19    person;
20        (3) the trigger that precipitated respiratory
21    distress, if identifiable;
22        (4) the location of where the symptoms developed;
23        (5) the number of doses administered;
24        (6) the type of person administering the asthma
25    medication (school nurse, trained personnel, or student);
26        (7) the outcome of the asthma medication

 

 

HB3926- 20 -LRB103 27612 RJT 53988 b

1    administration; and
2        (8) any other information required by the State Board.
3    (j) By October 1, 2015 and every year thereafter, the
4State Board of Education shall submit a report to the General
5Assembly identifying the frequency and circumstances of
6undesignated epinephrine and undesignated asthma medication
7administration during the preceding academic year. Beginning
8with the 2017 report, the report shall also contain
9information on which school districts, public schools, charter
10schools, and nonpublic schools maintain or have independent
11contractors providing transportation to students who maintain
12a supply of undesignated epinephrine injectors. This report
13shall be published on the State Board's Internet website on
14the date the report is delivered to the General Assembly.
15    (j-5) Annually, each school district, public school,
16charter school, or nonpublic school shall request an asthma
17action plan from the parents or guardians of a pupil with
18asthma. If provided, the asthma action plan must be kept on
19file in the office of the school nurse or, in the absence of a
20school nurse, the school administrator. Copies of the asthma
21action plan may be distributed to appropriate school staff who
22interact with the pupil on a regular basis, and, if
23applicable, may be attached to the pupil's federal Section 504
24plan or individualized education program plan.
25    (j-10) To assist schools with emergency response
26procedures for asthma, the State Board of Education, in

 

 

HB3926- 21 -LRB103 27612 RJT 53988 b

1consultation with statewide professional organizations with
2expertise in asthma management and a statewide organization
3representing school administrators, shall develop a model
4asthma episode emergency response protocol before September 1,
52016. Each school district, charter school, and nonpublic
6school shall adopt an asthma episode emergency response
7protocol before January 1, 2017 that includes all of the
8components of the State Board's model protocol.
9    (j-15) Every 2 years, school personnel who work with
10pupils shall complete an in-person or online training program
11on the management of asthma, the prevention of asthma
12symptoms, and emergency response in the school setting. In
13consultation with statewide professional organizations with
14expertise in asthma management, the State Board of Education
15shall make available resource materials for educating school
16personnel about asthma and emergency response in the school
17setting.
18    (j-20) On or before October 1, 2016 and every year
19thereafter, the State Board of Education shall submit a report
20to the General Assembly and the Department of Public Health
21identifying the frequency and circumstances of opioid
22antagonist administration during the preceding academic year.
23This report shall be published on the State Board's Internet
24website on the date the report is delivered to the General
25Assembly.
26    (k) The State Board of Education may adopt rules necessary

 

 

HB3926- 22 -LRB103 27612 RJT 53988 b

1to implement this Section.
2    (l) Nothing in this Section shall limit the amount of
3epinephrine injectors that any type of school or student may
4carry or maintain a supply of.
5(Source: P.A. 101-81, eff. 7-12-19; 102-413, eff. 8-20-21;
6102-813, eff. 5-13-22.)